[May 26, 2016]

Global Gastric Cancer Pipeline Report 2016 - Research and Markets

Research and Markets has announced the addition of the "Gastric Cancer - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Gastric Cancer , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastric Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Gastric Cancer Overview
3. Therapeutics Development
4. Pipeline Products for Gastric Cancer - Overview
5. Pipeline roducts for Gastric Cancer - Comparative Analysis
6. Gastric Cancer - Therapeutics under Development by Companies
7. Gastric Cancer - Therapeutics under Investigation by Universities/Institutes
8. Gastric Cancer Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Gastric Cancer - Products under Development by Companies
13. Gastric Cancer - Products under Investigation by Universities/Institutes
14. Gastric Cancer - Companies Involved in Therapeutics Development

• AB Science SA
• AbbVie Inc.
• AbGenomics International, Inc.
• ADC (News - Alert) Therapeutics Sarl
• Advaxis, Inc.
• Advenchen Laboratories, LLC
• BeiGene, Ltd.
• Betta Pharmaceuticals Co. Ltd.
• Bionovis SA
• Boehringer Ingelheim GmbH
• Boston Biomedical, Inc.
• Bristol-Myers Squibb Company
• Celgene Corporation
• Celldex Therapeutics, Inc.
• Cellectar Biosciences, Inc.
• Celltrion, Inc.
• Celon Pharma Sp. z o.o.
• Cerulean Pharma, Inc.
• Chipscreen Biosciences Ltd
• Chugai Pharmaceutical Co., Ltd.
• Compliment Corporation
• Curaxys, S.L.
• DAE HWA Pharmaceutical Co., Ltd.
• Daiichi Sankyo Company, Limited
• Deciphera Pharmaceuticals, LLC
• Dr. Reddy's Laboratories Limited
• Eddingpharm
• EirGenix Inc.
• Eli Lilly and Company
• Esperance Pharmaceuticals, Inc.
• Exelixis, Inc.
• F. Hoffmann-La Roche Ltd.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160526006195/en/

[ Back To TMCnet.com's Homepage ]